The Journal of community and supportive oncology
-
J Community Support Oncol · Mar 2014
An analysis of the variability of breakthrough pain intensity in patients with cancer.
The management of breakthrough pain in patients with cancer (BTPc) generally includes an initial titration of breakthrough pain medication to an effective dose, followed by the use of that dose in all subsequent episodes. This strategy presumes that an individual patient has a degree of consistency of pain during repeat episodes; however, that presumption has not been formally assessed. ⋯ The study was funded by Archimedes Development Ltd.